Global Cell Banking Outsourcing Market Size, Status and Forecast 2021-2027

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
Cell banking is a process of replicating and storing cells for the purpose of future use. Storage of these cell samples can be utilized for research purposes and for surgical reconstruction of damaged body structures. Cells are frozen in cryovials at -196 degrees Celsius along with cryoprotection agents such as 10% solution of DMSO. Cell banking is most commonly used in stem cell research and therapy.

Market Analysis and Insights: Global Cell Banking Outsourcing Market
The global Cell Banking Outsourcing market size is projected to reach US$ 20960 million by 2027, from US$ 6943.1 million in 2020, at a CAGR of 17.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Banking Outsourcing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Banking Outsourcing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Banking Outsourcing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Banking Outsourcing market.

Global Cell Banking Outsourcing Scope and Market Size
Cell Banking Outsourcing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Banking Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Stem Cell Banking
Non-stem Cell Banking

Segment by Application
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell